首页|心衰保元汤治疗PCI术后射血分数保留型心力衰竭疗效及对患者血清Gal-3、sST2的影响

心衰保元汤治疗PCI术后射血分数保留型心力衰竭疗效及对患者血清Gal-3、sST2的影响

扫码查看
目的:探讨心衰保元汤治疗经皮冠状动脉介入术(PCI)后射血分数保留型心力衰竭(HFpEF)的疗效及对患者血清半乳糖凝集素3(Gal-3)、可溶性致癌抑制因子2(sST2)的影响.方法:将PCI后发生HFpEF的患者86例随机分为两组,对照组(n=43)接受常规西医治疗,观察组(n=43)在对照组基础上加用心衰保元汤治疗,疗程为12周.记录两组临床疗效,比较两组治疗前后相关心功能指标、超声心动图指标、血清Gal-3、sST2水平.比较两组治疗后随访6个月时的心血管不良事件发生率.结果:观察组临床总有效率显著高于对照组(P<0.05).与治疗前比较,治疗后两组Lee氏心衰积评分、心功能NYHA分级、血清N末端脑钠肽原(NT-proBNP)、左室舒张末期内径(LVEDD)、左室收缩末期内径(LVESD)、左室质量指数(LVMI)均显著降低(P<0.05),且观察组降低程度高于对照组(P<0.05);观察组6 min步行试验距离、左室射血分数(LVEF)、舒张早期/晚期二尖瓣血流峰值(E/A)均增加(P<0.05),且观察组增加程度高于对照组(P<0.05).与治疗前比较,治疗后两组血清Gal-3、sST2水平均显著降低(P<0.05),且观察组降低程度高于对照组(P<0.05).观察组随访6个月时心血管不良事件发生率显著低于对照组(P<0.05).结论:在西医治疗基础上加用心衰保元汤可有效提高PCI后HFpEF的临床疗效,抑制心室重构,改善心脏功能,下调血清Gal-3、sST2表达水平,从而有利于降低心血管不良事件发生率.
Efficacy of Xinshuai Baoyuan decoction in the treatment of heart failure with preserved ejection fraction after PCI and its effect on serum Gal-3 and sST2
Objective:To investigate the efficacy of Xinshuai Baoyuan decoction in the treatment of heart failure with preserved ejection fraction(HFpEF)after percutaneous coronary intervention(PCI)and its effect on serum ga-lectin 3(Gal-3)and soluble oncogenic inhibitor 2(sST2).Methods:A total of 86 patients with HFpEF after PCI were randomly divided into two groups:the control group(n=43)received conventional western medicine treat-ment,and the observation group(n=43)was treated with Xinshuai Baoyuan decoction on the basis of the control group,and the course of treatment was 12 weeks.The clinical efficacy of the two groups was recorded,and the rele-vant cardiac function indexes,echocardiographic indicators,serum Gal-3 and sST2 levels were compared between the two groups before and after treatment.Results:The total clinical effective rate of observation group was higher than control group(P<0.05).Compared with before treatment,Lee's heart failure score,NYHA grade,serum N-termi-nal pro-brain natriuretic peptide(NT-proBNP),left ventricular end-diastolic diameter(LVEDD),left ventricular end-systolic diameter(LVESD)and left ventricular mass index(LVMI)were significantly reduced in the two groups af-ter treatment(P<0.05),and the reduction degree in the observation group was higher than that in the control group(P<0.05).The peak blood flow(E/A)of advanced mitral valve increased(P<0.05),and the increase degree in the observation group was higher than that in the control group(P<0.05).Compared with before treatment,the serum levels of Gal-3 and sST2 in the two groups were significantly decreased after treatment(P<0.05),and the reduction degree in the observation group was higher than that in the control group(P<0.05).Conclusion:On the basis of Western medicine treatment,the addition of Xinshuai Baoyuan decoction can effectively improve the clinical efficacy of HFpEF after PCI,inhibit ventricular remodeling,improve cardiac function,and down-regulate the expression levels of serum Gal-3 and sST2,which is conducive to reducing the incidence of cardiovascular adverse events.

Heart failure with preserved ejection fractionXinshuai Baoyuan decoctionPercutaneous coronary interventionGgalectin 3Soluble carcinogenic inhibitor 2Cardiac function

张悦、艾克荣

展开 >

西安市中医医院心血管病院,陕西西安 710021

射血分数保留型心力衰竭 心衰保元汤 经皮冠状动脉介入术 半乳糖凝集素3 可溶性致癌抑制因子2 心功能

2025

陕西中医
陕西省中医药学会

陕西中医

影响因子:1.101
ISSN:1000-7369
年,卷(期):2025.46(1)